Medium materiality6/10
AbbVie (ABBV) price target raised to $330 at RBC Capital
Why it may matterVerify against the original reporting
Bullish analyst view backed by the stated execution rationale.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
RBC Capital raised its ABBV price target to $330, versus the posted price of $288.91, citing a solid quarter and continued strong execution. The target implies moderate upside but is not a guarantee.
- RBC Capital target: $330
- Posted price: $288.91
- Headline cites a solid quarter and continued strong execution
Key facts
- 01
Target: $330
- 02
Posted price: $288.91
- 03
Analyst firm: RBC Capital
- 04
Analyst: Trung Huynh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.